Agilent Technologies Inc (NYSE:A) insider Mark Doak sold 15,567 shares of the business’s stock in a transaction on Monday, December 18th. The stock was sold at an average price of $68.00, for a total transaction of $1,058,556.00. Following the completion of the sale, the insider now directly owns 71,104 shares of the company’s stock, valued at $4,835,072. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Mark Doak also recently made the following trade(s):
- On Tuesday, December 5th, Mark Doak sold 4,154 shares of Agilent Technologies stock. The shares were sold at an average price of $67.00, for a total transaction of $278,318.00.
Shares of Agilent Technologies Inc (NYSE:A) traded up $0.93 during mid-day trading on Friday, reaching $71.73. 1,448,155 shares of the company’s stock were exchanged, compared to its average volume of 1,840,000. Agilent Technologies Inc has a twelve month low of $47.05 and a twelve month high of $72.33. The stock has a market capitalization of $23,080.00, a PE ratio of 34.32, a P/E/G ratio of 2.14 and a beta of 1.28. The company has a current ratio of 3.30, a quick ratio of 2.85 and a debt-to-equity ratio of 0.37.
Agilent Technologies (NYSE:A) last announced its quarterly earnings data on Monday, November 20th. The medical research company reported $0.67 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.62 by $0.05. The firm had revenue of $1.19 billion during the quarter, compared to analysts’ expectations of $1.17 billion. Agilent Technologies had a net margin of 15.30% and a return on equity of 16.95%. The company’s revenue for the quarter was up 7.0% compared to the same quarter last year. During the same period in the prior year, the company posted $0.59 earnings per share. sell-side analysts predict that Agilent Technologies Inc will post 2.58 earnings per share for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 24th. Stockholders of record on Tuesday, January 2nd will be paid a $0.149 dividend. The ex-dividend date is Friday, December 29th. This is a boost from Agilent Technologies’s previous quarterly dividend of $0.13. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.83%. Agilent Technologies’s dividend payout ratio is 28.71%.
A number of equities analysts have issued reports on the stock. Barclays restated a “buy” rating and issued a $74.00 price objective on shares of Agilent Technologies in a research report on Monday, January 8th. Evercore ISI initiated coverage on shares of Agilent Technologies in a research report on Wednesday, January 3rd. They issued an “outperform” rating and a $75.00 price objective on the stock. ValuEngine cut shares of Agilent Technologies from a “buy” rating to a “hold” rating in a research report on Friday, December 1st. Robert W. Baird reiterated a “buy” rating and set a $72.00 price target on shares of Agilent Technologies in a research report on Friday, November 24th. Finally, Cowen reiterated a “hold” rating and set a $70.00 price target on shares of Agilent Technologies in a research report on Wednesday, November 22nd. Six analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. Agilent Technologies presently has a consensus rating of “Buy” and a consensus target price of $68.98.
Hedge funds and other institutional investors have recently made changes to their positions in the company. Trexquant Investment LP purchased a new position in Agilent Technologies during the second quarter valued at $238,000. Schwab Charles Investment Management Inc. grew its stake in Agilent Technologies by 4.1% during the second quarter. Schwab Charles Investment Management Inc. now owns 1,314,078 shares of the medical research company’s stock valued at $77,938,000 after acquiring an additional 51,847 shares in the last quarter. Teacher Retirement System of Texas purchased a new position in Agilent Technologies during the second quarter valued at $200,000. Legal & General Group Plc grew its stake in Agilent Technologies by 7.0% during the second quarter. Legal & General Group Plc now owns 1,643,278 shares of the medical research company’s stock valued at $97,461,000 after acquiring an additional 107,529 shares in the last quarter. Finally, Comerica Bank grew its stake in Agilent Technologies by 0.7% during the second quarter. Comerica Bank now owns 82,619 shares of the medical research company’s stock valued at $5,081,000 after acquiring an additional 579 shares in the last quarter.
TRADEMARK VIOLATION NOTICE: This story was first published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this story on another site, it was illegally stolen and reposted in violation of U.S. and international copyright & trademark laws. The original version of this story can be read at https://www.dispatchtribunal.com/2018/01/13/insider-selling-agilent-technologies-inc-a-insider-sells-1058556-00-in-stock.html.
About Agilent Technologies
Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.